The latest cancer drugs news
Browsing: Cancer Drug News
Do certain diabetes drugs increase the risk of acute kidney injury in patients taking anti-cancer therapies?
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2…
New drug, WNTinib, delays tumor growth and improves survival in mouse models of children’s liver cancer
A new drug called WNTinib can delay the growth of tumours and improve survival in…
Experimental cancer drug eliminates bone metastases caused by breast cancer in lab models
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise…
Scientists discover chemical probes for previously “undruggable” cancer target
Hormone-driven cancers, like those of the breast and prostate, often rely on a tricky-to-target protein…
Significant worldwide disparities in availability and timeliness of new cancer drugs
Despite considerable progress in the discovery and development of new cancer drugs, there are significant…
FDA approves neoadjuvant/adjuvant nivolumab for resectable non-small cell lung cancer
On October 3, 2024, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers Squibb…
Researchers have successfully tested a new drug which can significantly extend the lives of breast cancer patients
Patients with advanced HER2-positive breast cancer very often develop brain metastases. When this happens, patients…
Seeing double: Designing drugs that target “twin” cancer proteins
Some proteins in the human body are easy to block with a drug; they have…
FDA approves amivantamab-vmjw with carboplatin and pemetrexed for non-small cell lung cancer with EGFR exon 19 deletions or L858R mutations
On September 19, 2024, the Food and Drug Administration approved amivantamab-vmjw with carboplatin and pemetrexed…
FDA approves selpercatinib for RET fusion-positive medullary thyroid cancer
On September 27, 2024, the Food and Drug Administration granted traditional approval to selpercatinib for…